Press release 26 April, 2022
Realheart has initiated the process of recruiting a new Chief Financial Officer to take over when current CFO Andreas Hultdin leaves on 31 July.
Realheart is a Swedish company headquartered in Västerås, which is developing the world's first artificial four-chamber heart. The company has recently taken several important steps forward, not least in leaving the prototype behind and instead test the clinical version of the Realheart TAH in the animal studies that are about to be initiated.
''As we step by step move closer the clinical trial phase, we see interest in the company growing among physicians, patients, the media and investors alike, and we need to have a dedicated, full-time CFO. Unfortunately, our current CFO Andreas Hultdin has commitments outside of Realheart and cannot extend his involvement, so we are looking for his successor instead'' said Ina Laura Perkins, CEO.
Andreas Hultdin will resign on July 31, but will stay on to support the company until a new CFO is in place.
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, Phone: +46 11 32 30 732, email: email@example.com
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atria and two ventricles) designed to generate a physiological blood flow pattern that mimics the body's natural circulation.Realheart to recruit new CFO (PDF)